putrescine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 3 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Motyl, T | 1 |
Kasterka, M | 1 |
Grzelkowska, K | 1 |
Blachowski, S | 1 |
Sysa, P | 1 |
Shardakov, VI | 1 |
Dem'ianova, VT | 2 |
Pankov, VN | 1 |
Sitnikov, SA | 1 |
VoronchikhĂna, LD | 1 |
Kostiaev, AA | 1 |
Berdinskikh, NK | 1 |
Beznosikova, TP | 1 |
3 other studies available for putrescine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
TGF-beta 1 inhibits polyamine biosynthesis in K 562 leukemic cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosylmethionine Decarboxylase; Apoptosis; Cell Div | 1993 |
[Polyamine and middle-molecule peptide levels in patients with chronic myeloid leukemia during treatment].
Topics: Antineoplastic Agents; Drug Resistance; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ne | 1990 |
[Fractional composition of free polyamines in the bone marrow and peripheral blood leukocytes in healthy persons and in patients with chronic leukemia].
Topics: Bone Marrow; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL | 1988 |